Prostatic neoplasm
Showing 26 - 50 of 2,222
Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)
Not yet recruiting
- Prostate Cancer With ≤10 Bone Metastases
- Apalutamide
- +2 more
- (no location specified)
Feb 22, 2023
Bladder Tumor, Prostate Tumor, Pelvic Tumor Trial in Edmonton (Rectus sheath block, Bilateral rectus sheath catheter, Patient
Completed
- Bladder Neoplasm
- +6 more
- Rectus sheath block
- +3 more
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jul 25, 2022
Breast Tumor, Prostatic Tumor, Colorectal Tumors Trial in United States (AH-HA Tool in the EPIC EHR)
Enrolling by invitation
- Breast Neoplasm
- +5 more
- AH-HA Tool in the EPIC EHR
-
Fort Smith, Arkansas
- +11 more
Dec 8, 2022
Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)
Not yet recruiting
- Prostate Cancer
- PSMA-PET/CT response evaluation
-
Utrecht, NetherlandsRoderick van den Bergh
Sep 10, 2022
oncRNA Stratification of Cancer by Size and Stage
Not yet recruiting
- Kidney Cancer
- +32 more
- Exai oncRNA blood test
- (no location specified)
Apr 27, 2023
Prostate Tumor, Genital Tumors, Male, Urogenital Tumors Trial in Miami, Chicago (Cultural CBSM, Standard CBSM)
Recruiting
- Prostate Neoplasm
- +5 more
- Cultural CBSM
- Standard CBSM
-
Miami, Florida
- +1 more
Dec 2, 2021
Prostatic Tumors, Tumor Metastasis Trial in Bergen, Tromsø, Trondheim (PSMA-PET, PSMA-PET/MRI, PSMA-PET/CT)
Recruiting
- Prostatic Neoplasms
- Neoplasm Metastasis
- PSMA-PET
- +2 more
-
Bergen, Norway
- +2 more
Feb 8, 2022
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Prostate Cancer, Tumor, Residual Trial in New York (LUM Imaging System)
Terminated
- Prostate Cancer
- Neoplasm, Residual
- LUM Imaging System
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Feb 8, 2022
Prostatic Tumor Trial in San Antonio (Home-Based Exercise Program)
Completed
- Prostatic Neoplasm
- Home-Based Exercise Program
-
San Antonio, Texas
- +1 more
Aug 6, 2021
Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)
Not yet recruiting
- Prostate Cancer
- +7 more
- (no location specified)
Jan 12, 2022
Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)
Recruiting
- Metastatic Prostate Cancer
- +4 more
- M7824
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Prostate Cancer, Prostate Tumor Trial in Nijmegen, Amsterdam (Ultrahypofractionated MR-guided radiotherapy boost)
Not yet recruiting
- Prostate Cancer
- Prostate Neoplasm
- Ultrahypofractionated MR-guided radiotherapy boost
-
Nijmegen, Gelderland, Netherlands
- +1 more
Nov 3, 2022
Detection Rate of Prostate Cancer in Men Undergoing MRI
Completed
- Prostatic Neoplasm
- multiparametric MRI
-
Candiolo, Turin, ItalyFondazione del Piemonte per l'Oncologia - Candiolo Cancer Instit
Apr 13, 2021
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
-
San Francisco, California
- +1 more
Sep 20, 2022
Strength, Aging, and Memory in Prostate Cancer
Active, not recruiting
- Prostate Neoplasm
- Prostate Cancer
- Androgen deprivation therapy
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Jul 13, 2022
Malignant Tumor of Prostate Trial in Cleveland ([F-18] NaF PET/CT, [F-18] fluciclovine PET/CT)
Withdrawn
- Malignant Neoplasm of Prostate
- [F-18] NaF PET/CT
- [F-18] fluciclovine PET/CT
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Mar 21, 2022
Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],
Recruiting
- Urologic Cancer
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- Pembrolizumab Injection [Keytruda]
- Salvage Radiation Therapy (SRT)
-
Freiburg, Baden-Württemberg, GermanyClinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022
MRI-Guided Cryoablation for Focal Native Prostate Cancer
Recruiting
- Primary Malignant Neoplasm of Prostate (Diagnosis)
- MR guided cryoablation
-
Rochester, MinnesotaMayo Clinic
Mar 18, 2022
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Recruiting
- Recurrent Prostate Cancer
- Biopsy
-
New York, New YorkColumbia University Medical Center
Mar 22, 2022
Prostatic Tumor Trial in Netherlands (Estetrol, Placebo Oral Tablet)
Completed
- Prostatic Neoplasm
- Estetrol
- Placebo Oral Tablet
-
Arnhem, Gelderland, Netherlands
- +5 more
Jun 16, 2021
Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)
Not yet recruiting
- Metastatic Cancer
- Neoplasm, Prostate
- Abiraterone acetate
- +2 more
-
Bronx, New YorkJames J. Peters VA Medical Center
Jun 16, 2022
Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)
Recruiting
- Prostate Cancer Metastatic
-
Peking, ChinaPeking Union Medical College Hospital
Nov 25, 2022
Malignant Tumor of Prostate Trial in Cleveland (Da Vinci ® Xi system - MP Robotic Radical Prostatectomy, Da Vinci ® SP system -
Not yet recruiting
- Malignant Neoplasm of Prostate
- Da Vinci ® Xi system - MP Robotic Radical Prostatectomy
- Da Vinci ® SP system - SP Robotic Radical Prostatectomy
-
Cleveland, OhioCase Comprehensive Cancer Center
Jun 1, 2022